Search Results - "Figueroa, Cristina Maria"

Relationship of circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancer by Xie, Eric, Lapinski, Maya M., Talamantes, Sarah, Nonyane, Bareng A. S., Magalhães, Maria Cristina Figueroa, Visvanathan, Kala, Wolff, Antonio C., Santa-Maria, Cesar A.

“…Purpose To evaluate the relationship of circulating immune cells with recurrence and metabolic/lifestyle factors in patients with early-stage breast cancer…”
Get full text

Value of Systemic Staging in Asymptomatic Early Breast Cancer by Soares, Gregório Pinheiro, Pereira, Allan Andresson Lima, Vilas Boas, Mariana Silva, Vaisberg, Victor Van, Magalhães, Maria Cristina Figueroa, Linck, Rudinei Diogo Marques, Mano, Max Senna

“…Metastases are rare in early breast cancer (EBC), and international guidelines recommend against routine systemic staging for asymptomatic patients. However,…”
Get full text

Treatment-related adverse events in patients with advanced breast cancer receiving adjuvant AKT inhibitors: a meta-analysis of randomized controlled trials by de Moraes, Francisco Cezar Aquino, Sano, Vitor Kendi Tsuchiya, Pereira, Caroline R. M., de Laia, Estella Aparecida, Stecca, Carlos, Magalhães, Maria Cristina Figueroa, Burbano, Rommel Mario Rodríguez

“…Introduction Incorporation of AKT inhibitors into adjuvant therapy for advanced or metastatic breast cancer has improved clinical outcomes. However, the safety…”
Get full text

Bilateral Gonadal Dysgerminoma in a Phenotypic Female With 46,XY Disorder of Sexual Development: A Case Report by Pasquini Neto, Ricardo, Carnielli Tebet, Maria Letícia, Ivanski Dória de Vasconcelos, Ohana, Faucz Munhoz da Cunha, Mariana, Figueroa Magalhães, Maria Cristina

“…The 46,XY disorder of sexual development (DSD) is a rare congenital condition characterized by a 46,XY karyotype associated with complete or disturbed female…”
Get full text

HLA-I and breast cancer prognosis: A systematic review and meta-analysis by Cezar Aquino de Moraes, Francisco, Henrique Cavalcanti Orestes Cardoso, Jorge, Alves Kelly, Francinny, Kreuz, Michele, Rodrigues Fernandes, Lilianne, Cristina Figueroa Magalhães, Maria, Mario Rodríguez Burbano, Rommel

“…Breast cancer (BC) is a significant global health issue, accounting for 1 in 8 cancer diagnoses worldwide. HLA class I molecules are typically expressed on the…”
Get full text

Bone-modifying agents as adjuvant therapy for early-stage breast cancer by Figueroa-Magalhães, Maria Cristina, Miller, Robert S

“…The development of effective systemic therapies to reduce the risk of disease recurrence or metastases in early-stage breast cancer remains an important…”
Get more information

Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer by Kim, Hyun-Seok, Umbricht, Christopher B, Illei, Peter B, Cimino-Mathews, Ashley, Cho, Soonweng, Chowdhury, Nivedita, Figueroa-Magalhaes, Maria Cristina, Pesce, Catherine, Jeter, Stacie C, Mylander, Charles, Rosman, Martin, Tafra, Lorraine, Turner, Bradley M, Hicks, David G, Jensen, Tyler A, Miller, Dylan V, Armstrong, Deborah K, Connolly, Roisin M, Fetting, John H, Miller, Robert S, Park, Ben Ho, Stearns, Vered, Visvanathan, Kala, Wolff, Antonio C, Cope, Leslie

“…Purpose Gene expression profiling assays are frequently used to guide adjuvant chemotherapy decisions in hormone receptor-positive, lymph node-negative breast…”
Get full text

Treatment of HER2-positive breast cancer by Figueroa-Magalhães, Maria Cristina, Jelovac, Danijela, Connolly, Roisin M, Wolff, Antonio C

“…Abstract The human epidermal growth factor receptor 2 gene ( HER2 ) is overexpressed and/or amplified in ∼15% of breast cancer patients and was identified a…”
Get full text

Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy versus Endocrine Therapy Alone for HR-Positive, HER-2-Negative Early Breast Cancer: Meta-Analysis of Phase III Randomized Clinical Trials by Moraes, Francisco Cezar Aquino de, de Oliveira Almeida, Gustavo, Alves, Vinícius Freire Costa, Priantti, Jonathan N, Gomes, Giovanna da Conceição, Carnevalli, Sarah Vitória Bristot, Madeira, Thiago, Vilbert, Maysa, Stecca, Carlos, Figueroa Magalhães, Maria Cristina, Fernandes, Marianne Rodrigues, Dos Santos, Ney Pereira Carneiro

“…Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors are approved for advanced breast cancer combined with endocrine therapy (ET). The efficacy of CDK4/6 inhibitors…”
Get full text

Ligand-mediated nanomedicines against breast cancer: a review by Picheth, Guilherme F, Ganzella, Fernando A de O, Filizzola, João Oc, Canquerino, Yan K, Cardoso, Gabriela C, Collini, Michelle B, Colauto, Leonardo B, Figueroa-Magalhães, Maria Cristina, Cavalieri, Edneia Asr, Klassen, Giseli

“…Ligand-mediated targeting represents the cutting edge in precision-guided therapy for several diseases. Surface engineering of nanomedicines with ligands…”
Get full text

Unraveling the Biogeochemical Dynamics of Pyrite Formation and Trace Element Incorporation in Marine Sediments by Figueroa, Maria Cristina

“…Past studies in paleoenvironmental reconstruction have set out to bridge the gap that limits our understanding of the biogeochemical controls in the past…”
Get full text

Omitting axillary lymph node dissection is associated with an increased risk of regional recurrence in early stage breast cancer: a systematic review and meta-analysis of randomized clinical trials by Cardoso, Jorge Henrique Cavalcanti Orestes, de Lara, Isabella Christina Amaral, Sobreira, Luis Eduardo Rodrigues, Lôbo, Artur de Oliveira Macena, Silvério, Iasmin Isabelli Luiz, Souza, Maria Eduarda Cavalcanti, de Moraes, Francisco Cezar Aquino, Magalhães, Maria Cristina Figueroa

“…•Breast cancer is a global problem that accounts for 12.5% cancer diagnoses worldwide;•There is a strong tendency in clinical practice to avoid the ALND as…”
Get full text

Real-world survival outcomes associated with use of pertuzumab and trastuzumab emtansine (T-DM1) for HER2-positive (HER2+) metastatic breast cancer (MBC) in Brazilian private healthcare setting by Dienstmann, Rodrigo, Cruz, Heloisa, Coelho Gonçalves, Aline, Andrade, Diocesio Alves Pinto de, Liedke, Pedro Emanuel Rubini, Costa, Rafael Brant, Dantas Loures da Costa, Mario Alberto, Boukai, Alexandre, Paes, Flavia Rocha, Landeiro, Luciana G., Gimenes, Daniel Luiz, Magalhaes, Maria Cristina Figueroa, Resende, Cristiano Augusto Andrade de, Reinert, Tomas, Aguiar Junior, Pedro N., Paes, Rafael, Costa e Silva, Matheus, Ferrari, Bruno Lemos, Mano, Max S.

“…e13022 Background: Breast cancer is a leading death cause of women in Brazil. There are increased concerns with limited access to innovative therapies and the…”
Get full text

Autologous Anti-CD19 CAR T-Cells immunotherapy in relapsed/refractory acute lymphoblastic leukemia patients. A systematic review and meta-analysis by Pasquini Neto, Ricardo, Mazzo, Felipe Antonio Torres, Bueno, Gustavo de Souza, Previdi, João Vitor Correa, Silva, Nasthia Kreuz Baziulis da, Vieira, Tulio da Silva, Magalhães, Maria Cristina Figueroa

“…Introduction: Acute Lymphoblastic Leukemia (ALL) is the most prevalent malignancy in children; however, when the neoplasm becomes refractory/relapses (R/R) the…”
Get full text

Healthcare Needs of U.S. Rural Latinos by Figueroa, Cristina, Medvin, Alexandra, Phrathep, Boondaniwon, Thomas, Chad, Ortiz, Judith, Bushy, Angeline

“…Purpose: From 2000 to 2050, the Latino population in the United States (U.S.) is expected to grow by 273%. Health outcomes vary widely among Latino subgroups…”
Get full text

Healthcare Needs of U.S. Rural Latinos: A Growing, Multicultural Population by Figueroa, Cristina Maria, Medvin, Alexandra, Phrathep, Boondaniwon D, Thomas, Chad W, Ortiz, Judith, Bushy, Angeline

“…From 2000 to 2050, the Latino population in the United States (U.S.) is expected to grow by 273%. Health outcomes among Latino subgroups and health disparities…”
Get full text

A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma by Cimino-Mathews, Ashley, Verma, Sangita, Figueroa-Magalhaes, Maria Cristina, Jeter, Stacie C., Zhang, Zhe, Argani, Pedram, Stearns, Vered, Connolly, Roisin M.

“…Objectives: Metaplastic breast carcinomas (MBCs) are rare, aggressive cancers lacking targeted therapy. Here, we review the clinicopathologic features,…”
Get full text

An estimation model for Oncotype DX recurrence score using routine histopathologic variables by Kim, Hyunseok, Umbricht, Christopher, Illei, Peter B., Magalhaes, Maria Cristina Figueroa, Pesce, Catherine, Gage, Michele Maiko, Mylander, Charles, Rosman, Martin, Tafra, Lorraine, Visvanathan, Kala, Cope, Leslie, Wolff, Antonio C.

“…Abstract only…”
Get full text

Autologous Anti-CD19 CAR T-Cells immunotherapy in relapsed/refractory acute lymphoblastic leukemia patients. A systematic review and meta-analysis/Imunoterapia de CAR T-Cells Anti-CD19 no tratamento de leucemia linfoblastica aguda refrataria/recidivante. Revisao sistematica e metanalise by Neto, Ricardo Pasquini, Mazzo, Felipe Antonio Torres, Bueno, Gustavo de Souza, Previdi, Joao Vitor Correa, da Silva, Nasthia Kreuz Baziulis, Vieira, Tulio da Silva, Magalhaes, Maria Cristina Figueroa

“…Introduction: Acute Lymphoblastic Leukemia (ALL) is the most prevalent malignancy in children; however, when the neoplasm becomes refractory/relapses (R/R) the…”
Get full text

Neocolagenização induzida pelo resurfacing com laser erbium:YAG isolado e associado a lifting cutâneo: estudo morfométrico comparativo em ratos Comparison of single erbium:YAG laser resurfacing to a combination with cutaneous lifting: a morphometric study of neocollagenization in rats by Lucia Noronha, Maria Cristina Figueroa, Paloma Rincón Tamanini, Ruth Graf

“…INTRODUÇÃO: Diferente do lifting, cuja tração mecânica é a responsável pelo efeito clínico de rejuvenescimento sobre rugas profundas, a fibroplasia (ou…”
Get full text